Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
Active & Responsive
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
Location: New York NY, The Bronx NY, Riverdale NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 65
Code: NCT07768371
Phase 3, Recruiting
Active & Responsive
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: New York NY, Hackensack NJ, Richmond VA, Cleveland OH,
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05722418
Phase 1, Recruiting
Active & Responsive
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase 3, Recruiting
Active & Responsive
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
for
Myelofibrosis; Anemia, Anemia, Myelofibrosis,
Location: New York NY, East Brunswick NJ, Philadelphia PA,
Sponsor: Disc Medicine, Inc
Sex: All
Age: 18+
Code: NCT05320198
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
for
Lung Non-Small Cell Carcinoma
Location: New York NY, The Bronx NY, Montvale NJ, Uniondale NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07293247
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
for
Acute Myeloid Leukemia
Location: New York NY, Montvale NJ, Rockville Centre NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 60+
Code: NCT07392242
Phase 2, Recruiting
Active & Responsive
A Study of Lung Cancer Risk
for
Lung Cancer
Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 40 - 70+
Code: NCT07701733
Recruiting
Active & Responsive
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
for
Solid Tumor, Non-Small-Cell Lung Cancer,
Location: New York NY, Hackensack NJ, Fairfax VA, Buffalo NY,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT07094204
Phase 1, Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: New York NY, Lake Success NY, New Brunswick NJ,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase 3, Recruiting
Active & Responsive
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for
Extensive Stage-small Cell Lung Cancer
Location: New York NY, Hackensack NJ, Mineola NY,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06362252
Phase 1, Phase 2, Recruiting
Active & Responsive
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
for
Coronavirus Disease (COVID-19)
Location: New York NY, Newark NJ, The Bronx NY, Annapolis MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06667700
Phase 3, Recruiting
Active & Responsive
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: New York NY, Englewood NJ, Florham Park NJ,
Sponsor: VM Oncology, LLC
Sex: All
Age: 18 - 70+
Code: NCT03556228
Phase 1, Phase 2, Recruiting
Active & Responsive
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
for
Castration Levels of Testosterone,
Location: New York NY, Hackensack NJ, The Bronx NY, Stamford CT,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT03678025
Phase 3, Recruiting
Active & Responsive
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for
Healthy
Location: New York NY, Jackson Heights NY, Flushing NY,
Sponsor: Pfizer
Sex: All
Age: 0 - 49
Code: NCT07160244
Phase 3, Recruiting
Active & Responsive
TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
for
Granulomatosis With Polyangiitis, Wegener's, GPA
Location: New York NY, Edison NJ
Sponsor: Robert Spiera, MD
Sex: All
Age: 18+
Code: NCT07176546
Phase 2, Phase 3, Recruiting
Active & Responsive
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
for
Focal Onset Seizures
Location: New York NY, Hackensack NJ, Neptune City NJ,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT06798896
Phase 2, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Brooklyn NY, New Windsor NY, Toms River NJ,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07231419
Phase 3, Recruiting
Active & Responsive
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
for
Type 2 Diabetes
Location: Long Island City NY, Staten Island NY, Pennington NJ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06897475
Phase 2, Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Staten Island NY, New York NY, The Bronx NY,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Phase 4, Recruiting
Active & Responsive
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for
Heart Failure With Preserved Ejection Fraction,
Location: Staten Island NY, New York NY, Newark NJ, Somerset NJ,